CollPlant Biotechnologies Ltd.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $463.0K |
| Cost of Revenue | $48.0K |
| Gross Profit | $415.0K |
| Gross Margin | 89.6% |
| Operating Expenses | |
| Research & Development | $584.0K |
| SG&A Expense | — |
| Operating Income | $-6.0M |
| Operating Margin | -1,286.6% |
| Interest Expense | — |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-6.1M |
| Net Margin | -1,306.9% |
| EPS (Basic) | — |
| EPS (Diluted) | — |
| Shares Outstanding (Basic) | 166.8M |
| Shares Outstanding (Diluted) | 166.8M |
| Dividends Per Share | — |